tiprankstipranks
Trending News
More News >
BriaCell Therapeutics (BCTX)
:BCTX
US Market

BriaCell Therapeutics (BCTX) Income Statement

Compare
265 Followers

BriaCell Therapeutics Income Statement

Last quarter (Q2 2025), BriaCell Therapeutics's total revenue was C$0.00, a decrease of ― from the same quarter last year. In Q2, BriaCell Therapeutics's net income was C$-6.29M. See BriaCell Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Sep 24Sep 23Sep 22Sep 21Sep 20
Total Revenue
C$ 0.00C$ 0.00C$ 0.00C$ 0.00C$ 0.00
Gross Profit
C$ 0.00C$ -20.49KC$ -19.39KC$ -19.44KC$ -18.74K
Operating Expenses
C$ 46.02KC$ 23.27MC$ 19.58KC$ 6.97MC$ 3.92M
Depreciation and Amortization
C$ 114.04KC$ 15.27KC$ 15.27KC$ 15.26KC$ 15.26K
EBITDA
-C$ -22.37MC$ -34.05MC$ -6.95MC$ -3.96M
Operating Income
-C$ -23.27MC$ -15.29MC$ -6.97MC$ -3.94M
Other Income/Expenses
C$ 39.21KC$ 2.97MC$ -11.69MC$ -8.54KC$ -113.00
Pretax Income
-C$ -20.30MC$ -26.84MC$ -13.82MC$ -4.03M
Net Income
-C$ -20.30MC$ -11.58MC$ -2.90MC$ 1.39M
Per Share Metrics
Basic EPS
C$ -6.03C$ -1.74C$ -1.73C$ -0.19C$ -5.64
Diluted EPS
C$ -6.03C$ -1.30C$ -1.73C$ -0.19C$ -5.64
Weighted Average Shares Outstanding
1.10M 15.62M 15.49M 301.31K 713.89K
Weighted Average Shares Outstanding (Diluted)
1.10M 15.62M 15.52M 301.31K 713.89K
Currency in CAD

BriaCell Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis